Skip to main content
Equibles
ETON logo

ETON · Eton Pharmaceuticals, Inc. · Analyst Estimates

Track ETON — free

Use ETON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ETON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$50.72 -0.23 (-0.45%) Play latest call Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.46B
Shares
28.58M
Volume · Nov 4 375.17K Avg daily vol (3M) 561.49K

Analyst Estimates

Compare analyst forecasts for Eton Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-04 14:04 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.28
1.40
1.52
2
1.40
1.40
1.40
1.05
0
0
2
1
Revenue
USD
Publication date not stated
147.60M
149.71M
152.30M
4
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
2.11
2.55
2.99
2
2.55
2.58
2.58
2.18
0
1
2
0
Revenue
USD
Publication date not stated
203.10M
220.38M
236.64M
4
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.32
0.37
0.42
2
0.37
0.37
0.37
0.31
0
0
2
1
Revenue
USD
Publication date not stated
40.50M
42.21M
43.12M
3
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.37
0.44
0.50
2
0.44
0.44
0.44
0.41
1
0
1
0
Revenue
USD
Publication date not stated
45.47M
46.36M
47.50M
3
 — — — — — — — —
Key facts CIK 1710340 CUSIP 29772L108 13F (30d) 59 filings 59 filers Visit website Investor relations